Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [scRNA-seq]

ABSTRACT: Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [scRNA-seq]

PROVIDER: PRJNA990769 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25119035_1.fastq.gz	Fastqsanger.gz
	SRR25119035_2.fastq.gz	Fastqsanger.gz
	SRR25119036_1.fastq.gz	Fastqsanger.gz
	SRR25119036_2.fastq.gz	Fastqsanger.gz
	SRR25119037_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia

Project description:Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia

| PRJNA990760 | ENA

Molecular fingerprints for bone marrow cells, pediatric acute lymphoblastic leukemia

Project description:Molecular fingerprints for bone marrow cells, pediatric acute lymphoblastic leukemia

| PRJNA958206 | ENA

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [scRNA-seq]

Project description:The overall goal of this study was to characterize bone marrow cells based on their transcriptome, surface protein expression and BCR-VDJ-profile for accurate identification of clinically relevant cell states. This submission includes B-cell acute lymphoblastic (pre-)leukemia samples from mice. This project has received funding from ERA perMed JTC2018 under the title „Genomics-based tools for personalized treatment to reduce chemotherapy burden in paediatric cancer” (Acronym “GEPARD”)

2023-07-04 | GSE236407 | GEO

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [bulk RNA-seq]

Project description:Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [bulk RNA-seq]

| PRJNA990764 | ENA

Molecular fingerprints for bone marrow cells, pediatric acute lymphoblastic leukemia

Project description:The overall goal of this study was to characterize bone marrow cells based on their transcriptome, surface protein expression and BCR- and TCR VDJ-profile for accurate identification of clinically relevant cell states. This submission includes pediatric B-cell acute lymphoblastic leukemia samples. This project has received funding from the European Union Horizon 2020 research and innovation programme under grant agreement No 824110 (EASI-Genomics)

2023-05-03 | GSE230295 | GEO

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [bulk RNA-seq]

Project description:The overall goal of this study was to characterize bone marrow cells based on their transcriptome. This submission includes preleukemic samples (B-cell acute lymphoblastic leukemia) from 6 mice. This project has received funding from ERA perMed JTC2018 under the title „Genomics-based tools for personalized treatment to reduce chemotherapy burden in paediatric cancer” (Acronym “GEPARD”)

2023-07-04 | GSE236406 | GEO

Bone Marrow - scRNA-sequencing

Project description:Bone Marrow - scRNA-sequencing

| PRJNA790965 | ENA

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-07-04 | GSE236408 | GEO

The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution

Project description:The bone marrow microenvironment of leukemia plays a key role in leukemia progression, but its molecular complexity in pre-B acute lymphoblastic leukemia (B-ALL), the most common cancer in children, remains poorly understood. Here we use single-cell RNA sequencing to characterise the bone marrow microenvironment during B-ALL progression.

2020-07-27 | GSE148115 | GEO

RNA-sequencing of pediatric acute lymphoblastic leukemia bone marrow mononuclear cells

Project description:The overall goal of this study was to profile pediatric acute lymphoblastic leukemia bone marrow tissue based on their transcriptome to characterize clinically relevant subtypes. This project has received funding from Cancer Society of Finland, Jane and Aatos Erkko Foundation and ERAPerMed (Reference Number: ERAPERMED2018-209) under the ERA-NET Cofund scheme of the Horizon 2020 Research and Innovation Framework Programme of the European Commission Research Directorate-General Grant Agreement No. 779282.

2023-04-05 | GSE228632 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data